Sirt3 enhances glioma cell viability by stabilizing Ku70–BAX interaction

References

• DeangelisLMBrain tumorsN Engl J Med2001344211412311150363
   PubMed Web of Science ®Google Scholar
• GaoJCirielloGSanderCSchultzNCollection, integration and analysis of cancer genomic profiles: from data to insightCurr Opin Genet Dev201424929824584084
   PubMed Web of Science ®Google Scholar
• LiuLLiWGengSSlit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patientsSurg Oncol201625440541027916173
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer StatisticsCA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• LiXZhengJDiaoHLiuYRUNX3 is down-regulated in glioma by Myc-regulated miR-4295J Cell Mol Med201620351852526756701
   PubMed Web of Science ®Google Scholar
• OsborneBBentleyNLMontgomeryMKTurnerNThe role of mitochondrial sirtuins in health and diseaseFree Radic Biol Med201610016417427164052
   PubMed Web of Science ®Google Scholar
• WinnikSAuwerxJSinclairDAMatterCMProtective effects of sirtuins in cardiovascular diseases: from bench to bedsideEur Heart J201536483404341226112889
   PubMed Web of Science ®Google Scholar
• YuWDittenhafer-ReedKEDenuJMSIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox statusJ Biol Chem201228717140781408622416140
   PubMed Web of Science ®Google Scholar
• ScherMBVaqueroAReinbergDSirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stressGenes Dev200721892092817437997
   PubMed Web of Science ®Google Scholar
• KoentgesCPfeilKMeyer-SteenbuckMPreserved recovery of cardiac function following ischemia-reperfusion in mice lacking SIRT3Can J Physiol Pharmacol2016941728026524632
   PubMed Web of Science ®Google Scholar
• Torrens-MasMOliverJRocaPSastre-SerraJSIRT3: oncogene and tumor suppressor in cancerCancers201791290
   Web of Science ®Google Scholar
• DesoukiMMDoubinskaiaIGiusDAbdulkadirSADecreased mitochondrial SIRT3 expression is a potential molecular biomarker associated with poor outcome in breast cancerHum Pathol20144551071107724746213
   PubMed Web of Science ®Google Scholar
• LiuYLiuYLChengWYinXMJiangBThe expression of SIRT3 in primary hepatocellular carcinoma and the mechanism of its tumor suppressing effectsEur Rev Med Pharmacol Sci201721597899828338198
   PubMed Web of Science ®Google Scholar
• YuWDenuRAKrautkramerKALoss of SIRT3 provides growth advantage for B cell malignanciesJ Biol Chem201629173268327926631723
   PubMed Web of Science ®Google Scholar
• LiuCHuangZJiangHShiFThe sirtuin 3 expression profile is associated with pathological and clinical outcomes in colon cancer patientsBiomed Res Int2014201419
   Web of Science ®Google Scholar
• CuiYQinLWuJSIRT3 enhances glycolysis and proliferation in SIRT3-expressing gastric cancer cellsPLoS One2015106e012983426121691
   PubMed Web of Science ®Google Scholar
• GeorgeJNihalMSinghCKZhongWLiuXAhmadNPro-proliferative function of mitochondrial sirtuin deacetylase SIRT3 in human melanomaJ Invest Dermatol2016136480981826743598
   PubMed Web of Science ®Google Scholar
• ChoiJKohELeeYSMitochondrial Sirt3 supports cell proliferation by regulating glutamine-dependent oxidation in renal cell carcinomaBiochem Biophys Res Commun2016474354755327114304
   PubMed Web of Science ®Google Scholar
• ZhangQFanHZouQTEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progressionJ Cell Mol Med20182273560357129667772
   PubMed Web of Science ®Google Scholar
• LiuHXuYZhangQCorrelations between TBL1XR1 and recurrence of colorectal cancerSci Rep201774427528295012
   PubMed Web of Science ®Google Scholar
• XuYYangXLiZSprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progressionOncotarget201783488828002800
   PubMedGoogle Scholar
• TanWPanMLiuHTianHYeQLiuHErgosterol peroxide inhibits ovarian cancer cell growth through multiple pathwaysOnco Targets Ther2017103467347428761355
   PubMed Web of Science ®Google Scholar
• LiuHZhangQLiKPrognostic significance of USP33 in advanced colorectal cancer patients: new insights into β-arrestin-dependent ERK signalingOncotarget2016749812238124027835898
   PubMedGoogle Scholar
• FlyRLloydJKruegerSFernieAvan der MerweMJImprovements to define mitochondrial metabolomics using nonaqueous fractionationMethods Mol Biol2015130519721025910736
   PubMedGoogle Scholar
• HouSduPWangPWangCLiuPLiuHSignificance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancerClin Transl Oncol20171991107111628332091
   PubMed Web of Science ®Google Scholar
• JohnsonMJBlandJMDavidsonPMThe relationship between two performance scales: New York Heart Association Classification and Karnofsky Performance Status ScaleJ Pain Symptom Manage201447365265823910628
   PubMed Web of Science ®Google Scholar
• SundaresanNRSamantSAPillaiVBRajamohanSBGuptaMPSIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70Mol Cell Biol200828206384640118710944
   PubMed Web of Science ®Google Scholar
• TrougakosIPLourdaMAntonelouMHIntracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complexClin Cancer Res2009151485919118032
   PubMed Web of Science ®Google Scholar
• ZhangQLiuHZhuQPatterns and functional implications of platelets upon tumor “education.”Int J Biochem Cell Biol201790688028754316
   PubMed Web of Science ®Google Scholar
• SawadaMSunWHayesPLeskovKBoothmanDAMatsuyamaSKu70 suppresses the apoptotic translocation of Bax to mitochondriaNat Cell Biol20035432032912652308
   PubMed Web of Science ®Google Scholar
• CohenHYLavuSBittermanKJAcetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosisMol Cell200413562763815023334
   PubMed Web of Science ®Google Scholar
• SubramanianCJarzembowskiJAOpipariAWCastleVPKwokRPHDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastomaNeoplasia201113872673421847364
   PubMed Web of Science ®Google Scholar
• ShuklaSFuPGuptaSApigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancerApoptosis201419588389424563225
   PubMed Web of Science ®Google Scholar
• PucciSMazzarelliPPaolaMSestiFInterleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progressionCell Cycle20098347348119177010
   PubMed Web of Science ®Google Scholar
• WangGFuXLWangJJGuanRSunYToSTInhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathwayJ Cell Physiol Epub1612018
   Web of Science ®Google Scholar
• SonMJRyuJSKimJYUpregulation of mitochondrial NAD+ levels impairs the clonogenicity of SSEA1+ glioblastoma tumor-initiating cellsExp Mol Med2017496e34428604662
   PubMed Web of Science ®Google Scholar
• SaloHSLaitinenTPosoAJarhoELahtela-KakkonenMIdentification of novel SIRT3 inhibitor scaffolds by virtual screeningBioorg Med Chem Lett201323102990299523562596
   PubMed Web of Science ®Google Scholar
• DischJSEvindarGChiuCHDiscovery of thieno[3,2-d] pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3J Med Chem20135693666367923570514
   PubMed Web of Science ®Google Scholar
• ChenYFuLLWenXSirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancerCell Death Dis201452e104724503539
   PubMed Web of Science ®Google Scholar
• SawadaMHayesPMatsuyamaSCytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70Nat Cell Biol20035435235712652309
   PubMed Web of Science ®Google Scholar
• ChengYDaiCZhangJSIRT3-SOD2-ROS pathway is involved in linalool-induced glioma cell apoptotic deathActa Biochim Pol201764234335028567457
   PubMed Web of Science ®Google Scholar